Age, (mean ± S.D.)
|
60.1 (13.7)
|
54.7 (15)
|
Women, n (%)
|
42 (85.7%)
|
28 (80%)
|
Disease duration, (month)
|
7.9 (2)
|
8.5 (1.2)
|
IgM RF positive, n (%)
|
34 (69.4%)
|
22 (62.9%)
|
Anti-CCP positive, n (%)
|
37 (75.5%)
|
26 (74.3%)
|
DAS28ESR , mean ± S.D.
|
6.1 (0.9)
|
6.4 (0.9)
|
CDAI, mean ± S.D.
|
36.2 (11.5)
|
33.6 (12.7)
|
Tender joint count, mean ± S.D.
|
13.1 (6.5)
|
14 (7.2)
|
Swollen joint count, mean ± S.D.
|
7.5 (5.9)
|
9.4 (5.2)
|
Patient global assessment (VAS 0–100), mean ± S.D.
|
65 (17.9)
|
64.3 (18.3)
|
ESR, mean ± S.D.
|
43.7 (22.4)
|
46.9 (33.5)
|
CRP, mean ± S.D.
|
27.5 (28.4)
|
40.3 (46.9)
|
HAQ-DI (0–3), mean ± S.D.
|
1.4 (0.7)
|
1.6 (0.7)
|